5-[3-(4-Isobutyl-phenyl)-[1,2,4]oxadiazol-5-yl]-pyridine-2-carbaldehyde → 4-[5-(4-Isopropoxy-phenyl)-1,2,4-oxadiazol-3-yl]benzaldehyde
反応式
[CH:1]([O:4][C:5]1[CH:10]=[CH:9][C:8]([C:11]2[O:15][N:14]=[C:13]([C:16]3[CH:21]=[CH:20][C:19]([CH2:22][OH:23])=[CH:18][CH:17]=3)[N:12]=2)=[CH:7][CH:6]=1)([CH3:3])[CH3:2].C(C1C=CC(C2N=C(C3C=CC(C=O)=NC=3)ON=2)=CC=1)C(C)C>>[CH:1]([O:4][C:5]1[CH:6]=[CH:7][C:8]([C:11]2[O:15][N:14]=[C:13]([C:16]3[CH:21]=[CH:20][C:19]([CH:22]=[O:23])=[CH:18][CH:17]=3)[N:12]=2)=[CH:9][CH:10]=1)([CH3:3])[CH3:2]参加物
3
実験手順
The title compound was prepared from 4-[5-(4-isopropoxy-phenyl)-[1,2,4]oxadiazol-3-yl]-phenylmethanol by procedures analogous to those described in Preparation 4F for the preparation of 5-[3-(4-isobutyl-phenyl)-[1,2,4]oxadiazol-5-yl]-pyridine-2-carbaldehyde.
出典と根拠
- ORDレコード
- ord-1f9c21d0ec794a458926cf6cd938aacb
- 出典データセット
- uspto-grants-2010_03